Hyaluronic acid and polyethylenimine self-assembled polyion complexes as pH-sensitive drug carrier for cancer therapy

•The PICs had negatively charged surface and were stable in physiological milieu.•The PICs could load small molecules and induce targeted drug delivery.•The PICs could behave pH responsive drug release behavior. In this study, a series of polyion complexes (PICs) were prepared via electrostatic inte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Colloids and surfaces, B, Biointerfaces B, Biointerfaces, 2015-10, Vol.134, p.81-87
Hauptverfasser: Chen, Jing-Xiao, Wang, Min, Tian, Hui-Hui, Chen, Jing-Hua
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 87
container_issue
container_start_page 81
container_title Colloids and surfaces, B, Biointerfaces
container_volume 134
creator Chen, Jing-Xiao
Wang, Min
Tian, Hui-Hui
Chen, Jing-Hua
description •The PICs had negatively charged surface and were stable in physiological milieu.•The PICs could load small molecules and induce targeted drug delivery.•The PICs could behave pH responsive drug release behavior. In this study, a series of polyion complexes (PICs) were prepared via electrostatic interaction between hyaluronic acid–histidine conjugate (HH) and polyethylenimine–histidine conjugate (PH). These PICs with the average size ranging from 410.5nm to 98.5nm at different weight ratios of HH/PH were able to encapsulate doxorubicin (DOX) as the model antitumor drug. The PICs at the weight ratio of 4:1 had negative surface charge and were of good dispersity and stability in the solution containing serum. In vitro drug release assay demonstrated that the DOX release rate were higher at acidic pH showing a controllable property. These HA coated PICs could targetedly deliver DOX to B16F10 tumor cells, showing improved antitumor activity.
doi_str_mv 10.1016/j.colsurfb.2015.06.039
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1778003435</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0927776515004233</els_id><sourcerecordid>1778003435</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-19813cfb1ff2399996f4c841aa8abd2cfaac54c9cf5438b411877dc28df52d3d3</originalsourceid><addsrcrecordid>eNqNkcFuFSEUhonR2NvqKzQs3cwIAwPMTtOo16RJN7omDBwsN8wwwkzjvL00t3Vr2XASvnNO-D-ErilpKaHi46m1KZYt-7HtCO1bIlrChlfoQJVkDWdCvkYHMnSykVL0F-iylBMhpONUvkUXnaB8GLg8oO24m7jlNAeLjQ0Om9nhJcUd1vs9whymMAMuEH1jSoFpjHB-D2nGNk1LhD9QsCl4OTYF5hLW8ADY5e0XtibnABn7lGs921qu95DNsr9Db7yJBd4_3Vfo59cvP26Oze3dt-83n28b2xOyNnRQlFk_Uu87NtQjPLeKU2OUGV1nvTG253awvudMjZzWz0tnO-V83znm2BX6cJ675PR7g7LqKRQLMZoZ0lY0lVIRwjjrX4ByoaTq-fAClHZ1bi9YRcUZtTmVksHrJYfJ5F1Toh9F6pN-FqkfRWoidBVZG6-fdmzjBO5f27O5Cnw6A1Dze6gx62ID1JBdyGBX7VL4346_m1u04w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1712780563</pqid></control><display><type>article</type><title>Hyaluronic acid and polyethylenimine self-assembled polyion complexes as pH-sensitive drug carrier for cancer therapy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Chen, Jing-Xiao ; Wang, Min ; Tian, Hui-Hui ; Chen, Jing-Hua</creator><creatorcontrib>Chen, Jing-Xiao ; Wang, Min ; Tian, Hui-Hui ; Chen, Jing-Hua</creatorcontrib><description>•The PICs had negatively charged surface and were stable in physiological milieu.•The PICs could load small molecules and induce targeted drug delivery.•The PICs could behave pH responsive drug release behavior. In this study, a series of polyion complexes (PICs) were prepared via electrostatic interaction between hyaluronic acid–histidine conjugate (HH) and polyethylenimine–histidine conjugate (PH). These PICs with the average size ranging from 410.5nm to 98.5nm at different weight ratios of HH/PH were able to encapsulate doxorubicin (DOX) as the model antitumor drug. The PICs at the weight ratio of 4:1 had negative surface charge and were of good dispersity and stability in the solution containing serum. In vitro drug release assay demonstrated that the DOX release rate were higher at acidic pH showing a controllable property. These HA coated PICs could targetedly deliver DOX to B16F10 tumor cells, showing improved antitumor activity.</description><identifier>ISSN: 0927-7765</identifier><identifier>EISSN: 1873-4367</identifier><identifier>DOI: 10.1016/j.colsurfb.2015.06.039</identifier><identifier>PMID: 26149947</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Antibiotics, Antineoplastic - administration &amp; dosage ; Antibiotics, Antineoplastic - chemistry ; CD44 receptor ; Cell Line, Tumor ; Conjugates ; Doxorubicin - administration &amp; dosage ; Doxorubicin - chemistry ; Drug Carriers ; Drug delivery systems ; Drugs ; Histidine ; Hyaluronic acid ; Hyaluronic Acid - chemistry ; Hydrogen-Ion Concentration ; Hydroxyapatite ; In vitro testing ; Ions ; Melanoma, Experimental - drug therapy ; Melanoma, Experimental - pathology ; Mice ; Microscopy, Electron, Transmission ; NIH 3T3 Cells ; pH sensitive ; Polyethyleneimine - chemistry ; Polyethylenimine ; Polyion complexes ; Therapy</subject><ispartof>Colloids and surfaces, B, Biointerfaces, 2015-10, Vol.134, p.81-87</ispartof><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-19813cfb1ff2399996f4c841aa8abd2cfaac54c9cf5438b411877dc28df52d3d3</citedby><cites>FETCH-LOGICAL-c500t-19813cfb1ff2399996f4c841aa8abd2cfaac54c9cf5438b411877dc28df52d3d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.colsurfb.2015.06.039$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26149947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Jing-Xiao</creatorcontrib><creatorcontrib>Wang, Min</creatorcontrib><creatorcontrib>Tian, Hui-Hui</creatorcontrib><creatorcontrib>Chen, Jing-Hua</creatorcontrib><title>Hyaluronic acid and polyethylenimine self-assembled polyion complexes as pH-sensitive drug carrier for cancer therapy</title><title>Colloids and surfaces, B, Biointerfaces</title><addtitle>Colloids Surf B Biointerfaces</addtitle><description>•The PICs had negatively charged surface and were stable in physiological milieu.•The PICs could load small molecules and induce targeted drug delivery.•The PICs could behave pH responsive drug release behavior. In this study, a series of polyion complexes (PICs) were prepared via electrostatic interaction between hyaluronic acid–histidine conjugate (HH) and polyethylenimine–histidine conjugate (PH). These PICs with the average size ranging from 410.5nm to 98.5nm at different weight ratios of HH/PH were able to encapsulate doxorubicin (DOX) as the model antitumor drug. The PICs at the weight ratio of 4:1 had negative surface charge and were of good dispersity and stability in the solution containing serum. In vitro drug release assay demonstrated that the DOX release rate were higher at acidic pH showing a controllable property. These HA coated PICs could targetedly deliver DOX to B16F10 tumor cells, showing improved antitumor activity.</description><subject>Animals</subject><subject>Antibiotics, Antineoplastic - administration &amp; dosage</subject><subject>Antibiotics, Antineoplastic - chemistry</subject><subject>CD44 receptor</subject><subject>Cell Line, Tumor</subject><subject>Conjugates</subject><subject>Doxorubicin - administration &amp; dosage</subject><subject>Doxorubicin - chemistry</subject><subject>Drug Carriers</subject><subject>Drug delivery systems</subject><subject>Drugs</subject><subject>Histidine</subject><subject>Hyaluronic acid</subject><subject>Hyaluronic Acid - chemistry</subject><subject>Hydrogen-Ion Concentration</subject><subject>Hydroxyapatite</subject><subject>In vitro testing</subject><subject>Ions</subject><subject>Melanoma, Experimental - drug therapy</subject><subject>Melanoma, Experimental - pathology</subject><subject>Mice</subject><subject>Microscopy, Electron, Transmission</subject><subject>NIH 3T3 Cells</subject><subject>pH sensitive</subject><subject>Polyethyleneimine - chemistry</subject><subject>Polyethylenimine</subject><subject>Polyion complexes</subject><subject>Therapy</subject><issn>0927-7765</issn><issn>1873-4367</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkcFuFSEUhonR2NvqKzQs3cwIAwPMTtOo16RJN7omDBwsN8wwwkzjvL00t3Vr2XASvnNO-D-ErilpKaHi46m1KZYt-7HtCO1bIlrChlfoQJVkDWdCvkYHMnSykVL0F-iylBMhpONUvkUXnaB8GLg8oO24m7jlNAeLjQ0Om9nhJcUd1vs9whymMAMuEH1jSoFpjHB-D2nGNk1LhD9QsCl4OTYF5hLW8ADY5e0XtibnABn7lGs921qu95DNsr9Db7yJBd4_3Vfo59cvP26Oze3dt-83n28b2xOyNnRQlFk_Uu87NtQjPLeKU2OUGV1nvTG253awvudMjZzWz0tnO-V83znm2BX6cJ675PR7g7LqKRQLMZoZ0lY0lVIRwjjrX4ByoaTq-fAClHZ1bi9YRcUZtTmVksHrJYfJ5F1Toh9F6pN-FqkfRWoidBVZG6-fdmzjBO5f27O5Cnw6A1Dze6gx62ID1JBdyGBX7VL4346_m1u04w</recordid><startdate>20151001</startdate><enddate>20151001</enddate><creator>Chen, Jing-Xiao</creator><creator>Wang, Min</creator><creator>Tian, Hui-Hui</creator><creator>Chen, Jing-Hua</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>JG9</scope><scope>L7M</scope></search><sort><creationdate>20151001</creationdate><title>Hyaluronic acid and polyethylenimine self-assembled polyion complexes as pH-sensitive drug carrier for cancer therapy</title><author>Chen, Jing-Xiao ; Wang, Min ; Tian, Hui-Hui ; Chen, Jing-Hua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-19813cfb1ff2399996f4c841aa8abd2cfaac54c9cf5438b411877dc28df52d3d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Antibiotics, Antineoplastic - administration &amp; dosage</topic><topic>Antibiotics, Antineoplastic - chemistry</topic><topic>CD44 receptor</topic><topic>Cell Line, Tumor</topic><topic>Conjugates</topic><topic>Doxorubicin - administration &amp; dosage</topic><topic>Doxorubicin - chemistry</topic><topic>Drug Carriers</topic><topic>Drug delivery systems</topic><topic>Drugs</topic><topic>Histidine</topic><topic>Hyaluronic acid</topic><topic>Hyaluronic Acid - chemistry</topic><topic>Hydrogen-Ion Concentration</topic><topic>Hydroxyapatite</topic><topic>In vitro testing</topic><topic>Ions</topic><topic>Melanoma, Experimental - drug therapy</topic><topic>Melanoma, Experimental - pathology</topic><topic>Mice</topic><topic>Microscopy, Electron, Transmission</topic><topic>NIH 3T3 Cells</topic><topic>pH sensitive</topic><topic>Polyethyleneimine - chemistry</topic><topic>Polyethylenimine</topic><topic>Polyion complexes</topic><topic>Therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Jing-Xiao</creatorcontrib><creatorcontrib>Wang, Min</creatorcontrib><creatorcontrib>Tian, Hui-Hui</creatorcontrib><creatorcontrib>Chen, Jing-Hua</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><jtitle>Colloids and surfaces, B, Biointerfaces</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Jing-Xiao</au><au>Wang, Min</au><au>Tian, Hui-Hui</au><au>Chen, Jing-Hua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyaluronic acid and polyethylenimine self-assembled polyion complexes as pH-sensitive drug carrier for cancer therapy</atitle><jtitle>Colloids and surfaces, B, Biointerfaces</jtitle><addtitle>Colloids Surf B Biointerfaces</addtitle><date>2015-10-01</date><risdate>2015</risdate><volume>134</volume><spage>81</spage><epage>87</epage><pages>81-87</pages><issn>0927-7765</issn><eissn>1873-4367</eissn><abstract>•The PICs had negatively charged surface and were stable in physiological milieu.•The PICs could load small molecules and induce targeted drug delivery.•The PICs could behave pH responsive drug release behavior. In this study, a series of polyion complexes (PICs) were prepared via electrostatic interaction between hyaluronic acid–histidine conjugate (HH) and polyethylenimine–histidine conjugate (PH). These PICs with the average size ranging from 410.5nm to 98.5nm at different weight ratios of HH/PH were able to encapsulate doxorubicin (DOX) as the model antitumor drug. The PICs at the weight ratio of 4:1 had negative surface charge and were of good dispersity and stability in the solution containing serum. In vitro drug release assay demonstrated that the DOX release rate were higher at acidic pH showing a controllable property. These HA coated PICs could targetedly deliver DOX to B16F10 tumor cells, showing improved antitumor activity.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26149947</pmid><doi>10.1016/j.colsurfb.2015.06.039</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0927-7765
ispartof Colloids and surfaces, B, Biointerfaces, 2015-10, Vol.134, p.81-87
issn 0927-7765
1873-4367
language eng
recordid cdi_proquest_miscellaneous_1778003435
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Antibiotics, Antineoplastic - administration & dosage
Antibiotics, Antineoplastic - chemistry
CD44 receptor
Cell Line, Tumor
Conjugates
Doxorubicin - administration & dosage
Doxorubicin - chemistry
Drug Carriers
Drug delivery systems
Drugs
Histidine
Hyaluronic acid
Hyaluronic Acid - chemistry
Hydrogen-Ion Concentration
Hydroxyapatite
In vitro testing
Ions
Melanoma, Experimental - drug therapy
Melanoma, Experimental - pathology
Mice
Microscopy, Electron, Transmission
NIH 3T3 Cells
pH sensitive
Polyethyleneimine - chemistry
Polyethylenimine
Polyion complexes
Therapy
title Hyaluronic acid and polyethylenimine self-assembled polyion complexes as pH-sensitive drug carrier for cancer therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T23%3A28%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyaluronic%20acid%20and%20polyethylenimine%20self-assembled%20polyion%20complexes%20as%20pH-sensitive%20drug%20carrier%20for%20cancer%20therapy&rft.jtitle=Colloids%20and%20surfaces,%20B,%20Biointerfaces&rft.au=Chen,%20Jing-Xiao&rft.date=2015-10-01&rft.volume=134&rft.spage=81&rft.epage=87&rft.pages=81-87&rft.issn=0927-7765&rft.eissn=1873-4367&rft_id=info:doi/10.1016/j.colsurfb.2015.06.039&rft_dat=%3Cproquest_cross%3E1778003435%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1712780563&rft_id=info:pmid/26149947&rft_els_id=S0927776515004233&rfr_iscdi=true